APA (7th ed.) Citation

A, M., JE, M., E, S., G, R., K, K., N, E., . . . AG, S. (2025). Quantitative [89Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 66(7), 1018. https://doi.org/10.2967/jnumed.124.268931

Chicago Style (17th ed.) Citation

A, Mansur, et al. "Quantitative [89Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine 66, no. 7 (2025): 1018. https://doi.org/10.2967/jnumed.124.268931.

MLA (9th ed.) Citation

A, Mansur, et al. "Quantitative [89Zr]Zr-Trastuzumab PET and Diffusion- Weighted MRI for Characterization of Metastatic HER2-Positive Breast Cancer with PET/MRI." Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine, vol. 66, no. 7, 2025, p. 1018, https://doi.org/10.2967/jnumed.124.268931.